Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

Alteogen, a South Korean biopharmaceutical company, has become the hottest stock on Korea’s KOSDAQ market, with its market ...

With the new operations site and logistics center in Sydney, “Australian researchers and biotech companies will no longer ...

As of September 30, 2024, Fortress' consolidated cash and cash equivalents totaled $58.9 million, compared to $76.2 million ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

Successfully navigating a drug development cycle is a major undertaking. On average, the sequence takes over a decade to ...

Sagimet Biosciences eyes major opportunities in MASH and Acne treatments. Find out why SGMT stock is a solid pick with upcoming phase 3 study results.

A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

Know the inspiring journey of Vivek Ramaswamy, the biotech entrepreneur, author, and political figure. From founding Roivant ...

According to a recent article in Biospace ,"The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, ...